70
Participants
Start Date
October 2, 2017
Primary Completion Date
September 26, 2018
Study Completion Date
September 26, 2018
CD14152 Dose A
3 subcutaneous injections (every 4 weeks during the 12-week treatment period)
CD14152 placebo
3 subcutaneous injections (every 4 weeks during the 12-week treatment period)
LKH-Univ. Klinikum Graz, Graz
Centre-Hospitalier Universitaire (CHU) - Hopital Morvan - Br, Brest
CHU de Nice - Hôpital Archet 2, Nice
Hopital Saint-Louis - Dermatology, Paris
Centre Hospitalier Universitaire De Toulouse, Toulouse
Charite - Campus Charite Mitte (CCM) - Dermatologie & Allergologie - Dermatologie & Allergologie, Berlin
Universitätsklinikum Bonn AöR, Bonn
Klinikum der Johann-Wolfgang Goethe-Universität, Frankfurt
Unikl. Schleswig-Holstein - Lübeck, Lübeck
Universitätsmedizin Mainz, Mainz
Klinikum Der Universität München - Campus Innenstadt - Dermatologie und Allergologie, München
Universitätsklinikum Münster, Münster
Eberhard-Karls Universitaet Tuebingen - Universitaets Hautkl, Tübingen
Centrum Medyczne DERMED, Lodz
Dermoklinika Centrum Medyczne s.c. M.Kierstan, J.Narbutt, A.Lesiak, Lodz
Kliniczny Szpital Wojew. nr 1 im. F.Chopina w Rzeszowie, Rzeszów
Lead Sponsor
Galderma R&D
INDUSTRY